BusinessTreos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal CancerBy Nasdaq OMXApr 11, 2018, 12:15 PM UTC
BusinessSunset Island Group Announces Update on Expansion and Retro Fit of GreenhouseBy Nasdaq OMXFeb 7, 2018, 3:16 PM UTC
BusinessOcera Announces Successful Phase 1 Clinical Study of Orally-Administered OCR-002 in Patients with CirrhosisBy Nasdaq OMXJan 5, 2017, 2:05 PM UTC
BusinessOcera Initiates Phase 1 Clinical Study of Orally Available OCR-002 in Patients with Cirrhosis for the Prevention of Hepatic EncephalopathyBy Nasdaq OMXSep 19, 2016, 1:05 PM UTC
BusinessAchillion Announces Upcoming Oral Presentation at the 57th Annual Meeting of the American Society of Hematology and Nomination of ACH-4471, a Novel Small Molecule Factor D Inhibitor, for Clinical DevelopmentBy Nasdaq OMXDec 5, 2015, 10:00 PM UTC
